Pepscan is a provider of peptide-based products and services, specializing in constrained peptides. As the inventor of the CLIPS™ constraining technology, Pepscan offers a new generation of biotherapeutics that exhibit antibody-like affinity and selectivity within small, fully synthetic molecules. The company is dedicated to supporting the pharmaceutical industry with innovative peptide solutions tailored for drug discovery collaborations.

Services include:
- Development of constrained peptides
- Custom peptide synthesis
- Peptide modification services
- Peptide libraries creation
- Analytical services for peptides
- Contract research services

Pepscan continues to lead in the field of peptide-based therapeutics, providing vital support to the pharmaceutical sector. For more information, visit pepscan.com.